After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
BioXcel Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of BioXcel Therapeutics Inc is $58.95M. A total of 2.68 million shares were traded on the day, compared to an average of 9.03M shares.
In the most recent transaction, O’Neill Vincent sold 165 shares of BTAI for 0.35 per share on Dec 16 ’24. After the transaction, the insider now owns 19,957 company shares. In a previous transaction on Dec 16 ’24, Mehta Vimal sold 3,117 shares at 0.36 per share. BTAI shares that CEO and President owns now total 59,605.
Among the insiders who sold shares, Steinhart Richard I disposed of 577 shares on Dec 16 ’24 at a per-share price of $0.36. This resulted in the Chief Financial Officer holding 20,932 shares of BTAI after the transaction. In another insider transaction, Rodriguez Javier sold 430 shares at $0.36 per share on Dec 16 ’24. Company shares held by the insider now total 24,423.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, BTAI has a high of $13.36 and a low of $1.17.
As of this writing, BTAI has an earnings estimate of -$1.13 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of -$0.62 per share and a lower estimate of -$1.54. The company reported an EPS of -$5.12 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. BTAI’s latest balance sheet shows that the firm has $232.97M in Cash & Short Term Investments as of fiscal 2021. There were $1.10M in debt and $16.67M in liabilities at the time. Its Book Value Per Share was -$16.26, while its Total Shareholder’s Equity was $221.67M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BTAI is Buy with a score of 3.83.
